Fundraising Fox
/People
Sign in

David Kaufman

Investor

Partner at Third Rock Ventures

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to David

165 people in our graph can introduce you to David.

Sign up to see every warm intro you have to David

  • Paths you didn't know you had: your email and LinkedIn already hold routes to David. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Physician-scientist who joined Third Rock Ventures as a venture partner in 2020 and became partner in 2022. He previously served as Chief Medical Officer and Head of Translational Development at the Gates Medical Research Institute and led Translational Oncology at Merck Research Laboratories.

Contact· published on David's own website

Invests in

BiotechDigital HealthMedical Devices

Experience

  1. Third Rock VenturesVenture Partner; Co-Founder, President and Head of R&D, Third Rock Ventures NewCocurrent2026 — present
  2. Third Rock VenturesPartner2022 — 2026
  3. Third Rock VenturesVenture Partner2020 — 2022Cambridge, Massachusetts, United States
  4. Abata TherapeuticsDirector2023 — 2025Greater Boston
  5. HOOKIPA Pharma Inc.Director2019 — 2025
  6. Asher BiotherapeuticsActing Head of Clinical and Translational Development2020 — 2022
  7. Bill & Melinda Gates Medical Research InstituteChief Medical Officer, Head of Translational Development2018 — 2020Cambridge, Massachusetts

Skills & more

Immunology23Vaccines25
  • Internal Medicine, Infectious Diseases — American Board of Internal Medicine

From David's professional profile.

Investments

Board seats

Abata TherapeuticsAbata TherapeuticsHookipa Pharma

Sources: the firm's website · SEC Form D filings.

Colleagues at Third Rock Ventures

Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
Operating Chairman at Curie.Bio
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures

Network5

Abbie Celniker
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures

Investors connected to David in public investor directories — a warm-intro map.

Frequently asked questions

Who is David Kaufman?
Physician-scientist who joined Third Rock Ventures as a venture partner in 2020 and became partner in 2022. He previously served as Chief Medical Officer and Head of Translational Development at the Gates Medical Research Institute and led Translational Oncology at Merck Research Laboratories.
Where does David Kaufman work?
David Kaufman is Partner at Third Rock Ventures.
What does David Kaufman invest in?
David Kaufman invests in Biotech, Digital Health, Medical Devices.
What check size does David Kaufman write?
David Kaufman typically writes checks of $100K – $5M.
What boards does David Kaufman sit on?
David Kaufman holds tracked board seats at Abata Therapeutics, Abata Therapeutics, Hookipa Pharma.
Where did David Kaufman go to school?
David Kaufman studied at Joan & Sanford I. Weill Medical College of Cornell University (Doctor of Medicine (MD)); The Rockefeller University (Doctor of Philosophy (PhD), Molecular Virology/Immunology).

Same school

Shared employers

Also worked at HOOKIPA Pharma Inc.1

Klaus OrlingerChief Scientific Officer at VALANX

Also worked at Asher Biotherapeutics1

Reid HuberPartner at Third Rock Ventures